An updated patent review of VEGFR-2 inhibitors (2017-present)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An updated patent review of VEGFR-2 inhibitors (2017-present)

Published:2021-06-14 Issue:11 Volume:31 Page:989-1007
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Farghaly Thoraya A.¹²,Al-Hasani Wedian A.²,Abdulwahab Hanan Gaber³

Affiliation:

1. Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt

2. Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia

3. Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1935872

Reference91 articles.

1. Angiogenesis in cancer and other diseases

2. Tumorigenesis and the angiogenic switch

3. Tumor angiogenesis: past, present and the near future

4. Targeting Angiogenesis in Renal Cell Carcinoma

5. The evolution of anti-angiogenic therapy for kidney cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies;Medicinal Chemistry;2024-11

2. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity;Bioorganic Chemistry;2024-10

3. Integrated pharmacophore‐based screening and docking strategy for identifying type II inhibitors of VEGFR‐2 kinase;Next Research;2024-10

4. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

5. Design, Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as VEGFR2 Kinase Inhibitors for Tumor Treatment;Chemical Research in Chinese Universities;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3